
Carnero's lab focuses on the search and characterization of new biomarkers in cancer. @ibis_sevilla @CSIC @HospitalUVRocio @unisevilla @CIBERONC @ContraCancerEs
Sevilla, Spain
Joined November 2019
- Tweets1.1K
- Following631
- Followers763
- Likes1.4K
📢El grupo de Biología Molecular del Cáncer del
@ibis_sevilla
(lnkd.in/evFCNhE8) busca personas interesadas en solicitar una Beca FPU para realizar su tesis doctoral en el área de Evolución Tumoral y Cáncer.
🤖 Made with AI
Yesterday at EACR 2026 Congress, our colleague Manuel presented one of lab’s latest work.
#EACR2026
Today at EACR2026 congress, our colleagues Asun (@aespinosa_9 ) and Julia are presenting their poster and sharing our lab’s latest work.
#EACR2026
This week, our colleagues Julia, Manuel and @aespinosa_9 are attending EACR 2026 congress in Budapest. @EACRnews
#EACR2026
Biología Molecular del Cáncer-IBiS retweeted
The European Union (EU) has a range of initiatives dedicated to establishing Open Access as the norm in scientific publishing.
Plan S and Horizon Europe both mandate that funded research be made fully Open Access.
Learn more: brnw.ch/21x35Ij
#MDPI #OpenAccess
📷
Emerging Roles of Hepatocellular Carcinoma Gene Signatures in Prognosis and Immunotherapy: Challenges and Opportunities
Amany Wahb, et al
Gene Expr. 2026;25(2):e00073.
doi:10.14218/GE.2025.00073
Ayer nuestro grupo participó en la Feria de la Ciencia de la ciencia con un taller titulado "Detectives del ADN: ¿Qué ocultan las células?"
@ibis_sevilla
@CSIC
#24FeriaCiencia
Biología Molecular del Cáncer-IBiS retweeted
Hoy voy a contarles de las verdaderas razones del envejecimiento cerebral acelerado, es este paper que salió en abril de 2026 y que todo el mundo está citando pero casi nadie lo está explicando.
Biología Molecular del Cáncer-IBiS retweeted
📄New #Editor’s Choice!
“#ArtificialIntelligence-Driven Personalization in #BreastCancer Screening: From Population Models to Individualized Protocols” by Filippo Pesapane et al.
🔓Read it free here: mdpi.com/2072-6694/17/17/290…
Targeting Histone Modifications in Colorectal Cancer: Therapeutic Potential of Epigenetic Modifiers on Acetylation, Methylation and Phosphorylation
by Abdeslam Jaafari
Gene Expression 2026;25(1):e00046
doi: 10.14218/GE.2025.00046
Biología Molecular del Cáncer-IBiS retweeted
¿Sabes realmente qué es el cáncer? ¿Por qué las células de nuestro cuerpo empiezan a crecer y crecer? 🔬El Dr. Marcos Malumbres, investigador en @VHIO nos ayuda a entenderlo #InvestigandoenCáncer
Biología Molecular del Cáncer-IBiS retweeted
📢NEW #SpecialIssue ON “Chronic Lymphocytic #Leukemia and Indolent B-Cell #Lymphomas: Clonal Evolution, Microenvironment, and Immune Remodeling.”
👨⚕️Guest Editor: Prof. Dr. Franco Fais @UniGenova
➡Look forward to receiving your submission at: mdpi.com/journal/cancers/spe…
Biología Molecular del Cáncer-IBiS retweeted
🔎A study published in #CancersMDPI claims that international guidelines recommending against #breast #thermography are based on obsolete evidence and should be updated.
✍by Ane Goñi-Arana, Jorge Pérez-Martín and Francisco Javier Díez. @UNED
🔗Full paper: mdpi.com/2072-6694/17/13/219…
Biología Molecular del Cáncer-IBiS retweeted
🌟Calling for Papers🌟
📚 New #SpecialIssue: Cancer and the #Brain: Brain and Tumor Interplay, the Nervous System's Vulnerabilities and Therapeutic Opportunities
👨🔬Guest Editor: Dr. Sylvia C. Kurz @YaleMed
🔗Find Out More: mdpi.com/journal/cancers/spe…
Biología Molecular del Cáncer-IBiS retweeted
📢Call for Papers! New #SpecialIssue “Metabolomic #Biomarkers for Cancers” edited by Prof. Dr. Emirhan Nemutlu & Dr. Burak Derkuş, is now open for submissions! 👏
🧐Discover More: mdpi.com/journal/cancers/spe…
🍀Please submit your manuscript and join this transformative journey.
Biología Molecular del Cáncer-IBiS retweeted
The Journal Relations Specialists (JRS) team are MDPI’s primary ambassadors to academic stakeholders.
In 2025, JRS engagement reached a new milestone: more than 16,000 meetings with academics worldwide.
Learn more: brnw.ch/21x1ckK
Biología Molecular del Cáncer-IBiS retweeted
📢 New #SpecialIssue Now Open for Submissions!
"Advances in Cancer #TargetedTherapy"
Edited by: Dr. Ponniah Selvakumar @JeffersonUniv
⏰ Deadline: 30 September 2026
Submit your manuscript and join this transformative journey ➡️ mdpi.com/journal/cancers/spe…

























